Literature DB >> 21598042

Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary.

Ja Seung Koo1, Haeryoung Kim.   

Abstract

Carcinoma of unknown primary (CUP) is a heterogeneous entity with different clinical and histological features. The aim of this study was to investigate the clinicopathological features and expression of proteins associated with carcinogenesis and tumor environment in different histological subtypes of CUP. Sixty-nine cases of CUP were subjected to immunohistochemistry for EGFR, phospho-EGFR, HER-2, phospho-HER-2, p53, ERCC1, RRM1, REDD1, HIF1α, COX-2, GLUT-1, 14-3-3σ, Phospho-mTOR, Phospho-S6, AMPKα1, Phospho-Akt, PDGF-β receptor, and caveolin-1, and fluorescence in situ hybridization for HER-2 gene amplification. Fourteen (20.3%) cases were poorly differentiated carcinoma, 24 (34.8%) were adenocarcinoma (AD), 17 (24.6%) were squamous cell carcinoma (SC), and 14 (20.3%) were undifferentiated carcinoma (UD). AD were mostly carcinomatosis type, while SC and UD were mostly nodal type (p < 0.001). SC showed more frequent EGFR overexpression (p < 0.001) and Glut-1 (p = 0.001). AD (p = 0.001) and carcinomatosis (p < 0.001) types showed shorter overall survival. SCs expressing Glut-1, HIF1α, and COX2 showed a poor prognosis (p = 0.048, 0.029, and 0.042, respectively). CUP shows various clinicopathological features according to the histological subtypes. SC is mainly associated with nodal metastasis in the head and neck, and frequent EGFR overexpression and Glut-1 expression. Glut-1, HIF1α, and COX2 expression in SC is associated with a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598042     DOI: 10.1007/s13277-011-0190-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.

Authors:  A J van de Wouw; M L G Janssen-Heijnen; J W W Coebergh; H F P Hillen
Journal:  Eur J Cancer       Date:  2002-02       Impact factor: 9.162

Review 2.  Perspectives for targeted therapies in cancer of unknown primary site.

Authors:  George Pentheroudakis; Nicholas Pavlidis
Journal:  Cancer Treat Rev       Date:  2006-12       Impact factor: 12.111

Review 3.  Metastases of undetermined source.

Authors:  E T Krementz; E J Cerise; D S Foster; L R Morgan
Journal:  Curr Probl Cancer       Date:  1979-11       Impact factor: 3.187

Review 4.  Metastasis of unknown origin.

Authors:  C M Haskell; A J Cochran; S H Barsky; R J Steckel
Journal:  Curr Probl Cancer       Date:  1988 Jan-Feb       Impact factor: 3.187

5.  Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?

Authors:  George Pentheroudakis; Evangelos Briasoulis; Vassilis Karavassilis; George Fountzilas; Nikolaos Xeros; George Samelis; Epaminondas Samantas; Nicholas Pavlidis
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

6.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

7.  Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis.

Authors:  Mateja Legan; Bostjan Luzar; Vera Ferlan Marolt
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

8.  Glucose transporter-1 expression in squamous cell carcinoma of the tongue.

Authors:  Yoon Seok Choi; Seok Jin Kim; Dae Sik Kim; Seh Jong Park; Yong Park; Hye Jin Shin; Kwang-Yoon Jung; Seung-Kuk Baek; Bong Kyung Shin; Jung Woo Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

9.  Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients.

Authors:  A W Eckert; M H W Lautner; H Taubert; J Schubert; U Bilkenroth
Journal:  Oncol Rep       Date:  2008-12       Impact factor: 3.906

Review 10.  A microenvironmental model of carcinogenesis.

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

View more
  6 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

Review 2.  Cancers of unknown primary origin: current perspectives and future therapeutic strategies.

Authors:  Giulia Maria Stella; Rebecca Senetta; Adele Cassenti; Margherita Ronco; Paola Cassoni
Journal:  J Transl Med       Date:  2012-01-24       Impact factor: 5.531

3.  Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.

Authors:  Sheng Chen; Ye Wang; Wen-Long Zhang; Mao-Sheng Dong; Jian-Hua Zhang
Journal:  Mol Med Rep       Date:  2017-02-08       Impact factor: 2.952

4.  The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis.

Authors:  Susu Han; Tao Huang; Fenggang Hou; Liting Yao; Xiyu Wang; Xing Wu
Journal:  Ther Adv Med Oncol       Date:  2019-09-24       Impact factor: 8.168

Review 5.  Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?

Authors:  Ekaterina M Zhidkova; Evgeniya S Lylova; Diana D Grigoreva; Kirill I Kirsanov; Alena V Osipova; Evgeny P Kulikov; Sergey A Mertsalov; Gennady A Belitsky; Irina Budunova; Marianna G Yakubovskaya; Ekaterina A Lesovaya
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

6.  Expression of Glycolysis-Related Proteins in Cancer of Unknown Primary Origin.

Authors:  Murilo Bonatelli; Isabella Fernandes Fornari; Priscila Neves Bernécule; Lara Esquiapatti Pinheiro; Ricardo Filipe Alves Costa; Adhemar Longatto-Filho; João Neif Antonio Junior; Eduardo Caetano Albino Silva; Flávio Mavignier Cárcano; Céline Pinheiro
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.